NCT05664516View on ClinicalTrials.gov

A Study of the Effects of Oxytocin in Adults With Binge-eating Disorder

PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 7, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Binge-eating Disorder
Interventions
DRUG

TNX-1900 (Tonix Pharmaceuticals)

oxytocin nasal spray

DRUG

Placebo

Nasal solution without oxytocin

Trial Locations (1)

02114

RECRUITING

Neuroendocrine Unit Research Center, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER